| |
| |
|
| Insider
Information: |
Tammenoms Bakker Juliet |
| Relationship: |
|
| City: |
Menlo Park |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
10 |
|
| Direct
Shares |
190,546 |
|
|
Indirect Shares
|
34,191,873 |
|
|
| Direct
Value |
$6,371,625 |
|
|
|
Indirect Value
|
$650,206,579 |
|
|
| Total
Shares |
34,382,419 |
|
|
| Total
Value |
$656,578,203 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
5
|
13
|
|
Stock
price went up :
|
3
|
12
|
| Stock
price went down : |
2
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
1.5
|
12.0
|
| Percentage
Gain/Loss : |
 10.4%
|
1,186.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Corcept Therapeutics Inc |
CORT |
10% Owner |
2016-12-15 |
133,539 |
2016-12-15 |
10,956,002 |
Premium* |
|
|
Esperion Therapeutics, Inc. |
ESPR |
10% Owner |
2013-07-01 |
0 |
2014-11-18 |
28,186 |
Premium* |
|
|
Aimmune Therapeutics, Inc. |
AIMT |
10% Owner |
2018-02-22 |
16,651 |
2018-02-22 |
6,013,134 |
Premium* |
|
|
Molecular Templates, Inc. |
MTEM |
10% Owner |
2018-09-21 |
0 |
2020-08-28 |
3,202,530 |
Premium* |
|
|
Axonics Modulation Technologies,... |
AXNX |
Director |
2020-09-18 |
3,500 |
2020-09-18 |
1,956,359 |
Premium* |
|
|
Venus Concept Inc |
VERO |
Director, 10% Owner |
2019-11-07 |
0 |
2019-11-07 |
3,666,119 |
Premium* |
|
|
Eargo, Inc. |
EAR |
Director, 10% Owner |
2021-05-17 |
7,016 |
2021-05-17 |
3,008 |
Premium* |
|
|
Tourmaline Bio |
TRML |
10% Owner |
2021-05-11 |
0 |
2021-05-11 |
3,220,775 |
Premium* |
|
|
Vera Therapeutics, Inc. |
VERA |
10% Owner |
2021-05-18 |
0 |
2023-02-06 |
5,144,212 |
Premium* |
|
|
Rxsight, Inc. |
RXST |
|
2024-02-14 |
29,840 |
2024-02-14 |
1,548 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
96 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ESPR |
Esperion Therapeutics, In... |
10% Owner |
– – • |
2014-11-18 |
4 |
S |
$31.56 |
$161,346 |
I/I |
(5,104) |
28,186 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
10% Owner |
– – • |
2016-11-16 |
4 |
S |
$9.51 |
$162,142 |
D/D |
(17,052) |
14,345,521 |
0 |
- |
|
| RXST |
Rxsight, Inc. |
Director |
– • – |
2021-08-03 |
4 |
B |
$16.00 |
$200,000 |
D/D |
12,500 |
18,359 |
2.39 |
% |
|
| RXST |
Rxsight, Inc. |
|
– • – |
2024-02-12 |
4 |
B |
$50.38 |
$201,520 |
D/D |
4,000 |
25,840 |
0.01 |
% |
|
| RXST |
Rxsight, Inc. |
|
– • – |
2024-02-14 |
4 |
B |
$51.29 |
$205,153 |
D/D |
4,000 |
29,840 |
0.01 |
% |
|
| CORT |
Corcept Therapeutics Inc |
10% Owner |
– – • |
2014-03-05 |
4 |
S |
$4.01 |
$286,568 |
D/D |
(71,467) |
186,325 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
10% Owner |
– – • |
2018-02-22 |
4 |
B |
$32.00 |
$300,000 |
D/D |
9,375 |
16,651 |
2.45 |
- |
|
| RXST |
Rxsight, Inc. |
|
– • – |
2023-09-08 |
4 |
S |
$30.25 |
$303,461 |
D/D |
(10,033) |
23,173 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
10% Owner |
– – • |
2014-05-02 |
4 |
S |
$4.07 |
$351,979 |
D/D |
(86,443) |
172,992 |
0 |
- |
|
| ESPR |
Esperion Therapeutics, In... |
10% Owner |
– – • |
2014-10-07 |
4 |
S |
$30.04 |
$358,289 |
I/I |
(11,927) |
37,776 |
0 |
- |
|
| AXNX |
Axonics Modulation Techno... |
Director |
– • – |
2020-09-18 |
4 |
S |
$42.67 |
$391,119 |
D/D |
(9,167) |
3,500 |
0 |
% |
|
| RXST |
Rxsight, Inc. |
|
– • – |
2023-08-18 |
4 |
S |
$29.07 |
$425,877 |
D/D |
(14,651) |
68,411 |
0 |
% |
|
| RXST |
Rxsight, Inc. |
|
– • – |
2023-08-25 |
4 |
S |
$29.25 |
$474,129 |
D/D |
(16,208) |
53,173 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
10% Owner |
– – • |
2008-11-11 |
4 |
A |
$1.45 |
$506,666 |
D/D |
349,425 |
3,879,875 |
0 |
- |
|
| RXST |
Rxsight, Inc. |
|
– • – |
2023-08-17 |
4 |
S |
$30.06 |
$555,694 |
D/D |
(18,484) |
83,062 |
0 |
% |
|
| RXST |
Rxsight, Inc. |
|
– • – |
2023-09-07 |
4 |
S |
$30.10 |
$600,983 |
D/D |
(19,967) |
33,206 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
10% Owner |
– – • |
2014-03-06 |
4 |
S |
$4.00 |
$672,530 |
D/D |
(168,103) |
183,022 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
10% Owner |
– – • |
2014-05-01 |
4 |
S |
$4.12 |
$674,591 |
D/D |
(163,557) |
174,691 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
10% Owner |
– – • |
2014-04-01 |
4 |
S |
$4.28 |
$1,070,575 |
D/D |
(250,000) |
177,905 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
10% Owner |
– – • |
2010-04-21 |
4 |
OE |
$1.66 |
$1,422,029 |
D/D |
856,644 |
11,826,929 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
10% Owner |
– – • |
2016-11-15 |
4 |
S |
$9.55 |
$1,474,653 |
D/D |
(154,359) |
14,362,573 |
0 |
- |
|
| MTEM |
Molecular Templates, Inc. |
10% Owner |
– – • |
2018-09-21 |
4 |
B |
$5.50 |
$2,007,500 |
I/I |
365,000 |
3,261,535 |
1.5 |
- |
|
| CORT |
Corcept Therapeutics Inc |
10% Owner |
– – • |
2012-03-29 |
4 |
OE |
$2.96 |
$2,535,666 |
D/D |
856,644 |
13,433,573 |
0 |
- |
|
| RXST |
Rxsight, Inc. |
|
– • – |
2023-11-14 |
4 |
S |
$27.13 |
$2,712,590 |
I/I |
(100,000) |
894,313 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
Director |
– • • |
2011-01-21 |
4 |
B |
$3.90 |
$2,925,000 |
D/D |
750,000 |
12,576,929 |
3.92 |
- |
|
96 Records found
|
|
Page 3 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
